Zhejiang Huahai Pharmaceutical(600521.SH): Telmisartan tablets obtain medicinal registration certificate
(600521.SH) Announcement: The company recently received a notice from the National Medical Products Administration (referred to as "NMPA")...
Zhejiang Huahai Pharmaceutical (600521.SH) announced that the company recently received the Drug Registration Certificate for Telmisartan Tablets issued by the National Medical Products Administration (referred to as the "NMPA"). Telmisartan tablets are used to treat hypertension and reduce cardiovascular risk.
Related Articles
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
